Please login to the form below
Mallinckrodt
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mallinckrodt's Japan sales performance.
Mallinckrodt doses first patient in muscular dystrophy trial
Mallinckrodt doses first patient in muscular dystrophy trial. Repurposed drug could help delay decline in muscle function. ... Mallinckrodt has kicked off a phase II trial of its Duchenne muscular dystrophy candidate, a repurposed drug used for years for
Deal Watch January 2018
Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International. RECOTHROM® Thrombin topical and PREVELEAK® Surgical Sealant to control bleeding in surgery.
Mallinckrodt pays $1.2bn for Sucampo Pharma
Mallinckrodt pays $1.2bn for Sucampo Pharma. The Irish group will acquire Amitizia, Rescula and a pipeline of rare disease projects. ... As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug
Pharma deals continue to slide
products. While this may not have been the reason behind GSK’s termination of its rare disease projects, it has not deterred Mallinckrodt from acquiring Infacare, a US company with a ... 469 (upfront 31). Infacare (US). Mallinckrodt (US/GB). Company
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Director, Market Access / HEOR - North-West
-
Negotiable
-
Associate Medical Director
-
Highly Competitive
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior Account Manager
-
Negotiable
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Associate Director
-
£75, 000-90, 000
-
Senior Medical Writer
-
Competitive Salary
-
Medical Writers
-
Competitive Salary and Benefits
-
Account Director
-
£48, 000 - £60, 000
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Senior Medical Writer
-
Great salary and benefits
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
-
Account Director
-
Excellent benefits
Subscribe to our email news alerts
- Vitreoretinal Surgery Devices Market Is Expected To Generate Huge Profits by 2017-2027
- Hirschsprung Disease Treatment Market Healthy Pace throughout the Forecast during 2017 – 2027
- Wavefront Aberrometers Market is Set to Experience Revolutionary Growth by 2027
- Endoscopy Fluid Management Systems Market Poised to Expand at a Robust Pace Over 2017 – 2027
- Primary Biliary Cholangitis (PBC) Treatment Market Investment Research Report 2017 – 2027
- Roche gains speedy review for Tecentriq in first-line breast cancer
PMHub
M&F Health
M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
